Search Results

There are 60352 results for: content related to: Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial

  1. You have free access to this content
    TNF-alpha inhibitors for ankylosing spondylitis

    Intervention Review

    The Cochrane Library

    Lara J Maxwell, Jane Zochling, Annelies Boonen, Jasvinder A Singh, Mirella MS Veras, Elizabeth Tanjong Ghogomu, Maria Benkhalti Jandu, Peter Tugwell and George A Wells

    Published Online : 18 APR 2015, DOI: 10.1002/14651858.CD005468.pub2

  2. You have full text access to this OnlineOpen article
    A Randomized, Double-Blind, Placebo-Controlled, Sixteen-Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis

    Arthritis & Rheumatology

    Volume 67, Issue 10, October 2015, Pages: 2702–2712, J. Sieper, D. van der Heijde, M. Dougados, W. P. Maksymowych, B. B. Scott, J. A. Boice, Y. Berd, G. Bergman, S. Curtis, A. Tzontcheva, S. Huyck and H. H. Weng

    Version of Record online : 23 SEP 2015, DOI: 10.1002/art.39257

  3. You have free access to this content
    Golimumab in psoriatic arthritis: One-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial

    Arthritis & Rheumatism

    Volume 64, Issue 8, August 2012, Pages: 2504–2517, Arthur Kavanaugh, Désirée van der Heijde, Iain B. McInnes, Philip Mease, Gerald G. Krueger, Dafna D. Gladman, Juan Gómez-Reino, Kim Papp, Anna Baratelle, Weichun Xu, Surekha Mudivarthy, Michael Mack, Mahboob U. Rahman, Zhenhua Xu, Julie Zrubek and Anna Beutler

    Version of Record online : 27 JUL 2012, DOI: 10.1002/art.34436

  4. Golimumab for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Jasvinder A Singh, Shahrzad Noorbaloochi and Gurkirpal Singh

    Published Online : 20 JAN 2010, DOI: 10.1002/14651858.CD008341

  5. You have free access to this content
    Golimumab, a Human Anti–Tumor Necrosis Factor Monoclonal Antibody, Injected Subcutaneously Every 4 Weeks in Patients With Active Rheumatoid Arthritis Who Had Never Taken Methotrexate: 1-Year and 2-Year Clinical, Radiologic, and Physical Function Findings of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

    Arthritis Care & Research

    Volume 65, Issue 11, November 2013, Pages: 1732–1742, Paul Emery, Roy M. Fleischmann, Mittie K. Doyle, Ingrid Strusberg, Patrick Durez, Peter Nash, Eric Amante, Melvin Churchill, Won Park, Bernardo Pons-Estel, Weichun Xu, Stephen Xu, Zhong Wu and Elizabeth C. Hsia

    Version of Record online : 28 OCT 2013, DOI: 10.1002/acr.22072

  6. Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Alomgir Hossain, Elizabeth Tanjong Ghogomu, Ahmed Kotb, Robin Christensen, Amy S Mudano, Lara J Maxwell, Nipam P Shah, Peter Tugwell and George A Wells

    Published Online : 13 MAY 2016, DOI: 10.1002/14651858.CD012183

  7. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  8. You have free access to this content
    Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double-blind, placebo-controlled, dose-ranging study

    Arthritis & Rheumatism

    Volume 58, Issue 4, April 2008, Pages: 964–975, Jonathan Kay, Eric L. Matteson, Bhaskar Dasgupta, Peter Nash, Patrick Durez, Stephen Hall, Elizabeth C. Hsia, John Han, Carrie Wagner, Zhenhua Xu, Sudha Visvanathan and Mahboob U. Rahman

    Version of Record online : 27 MAR 2008, DOI: 10.1002/art.23383

  9. Adverse effects of biologics: a network meta-analysis and Cochrane overview

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, George A Wells, Robin Christensen, Elizabeth Tanjong Ghogomu, Lara J Maxwell, John K MacDonald, Graziella Filippini, Nicole Skoetz, Damian K Francis, Luciane C Lopes, Gordon H Guyatt, Jochen Schmitt, Loredana La Mantia, Tobias Weberschock, Juliana F Roos, Hendrik Siebert, Sarah Hershan, Chris Cameron, Michael PT Lunn, Peter Tugwell and Rachelle Buchbinder

    Published Online : 16 FEB 2011, DOI: 10.1002/14651858.CD008794.pub2

  10. You have full text access to this OnlineOpen article
    Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 5, September 2015, Pages: 504–514, P. Rutgeerts, B. G. Feagan, C. W. Marano, L. Padgett, R. Strauss, J. Johanns, O. J. Adedokun, C. Guzzo, H. Zhang, J.-F. Colombel, W. Reinisch, P. R. Gibson, W. J. Sandborn and for the PURSUIT-IV study group

    Version of Record online : 29 JUN 2015, DOI: 10.1111/apt.13291

  11. Lack of Racial Differences in the Pharmacokinetics of Subcutaneous Golimumab in Healthy Japanese and Caucasian Male Subjects

    The Journal of Clinical Pharmacology

    Volume 50, Issue 7, July 2010, Pages: 792–802, Dr Jie Ling, Ms Sally Lyn, Dr Zhenhua Xu, Dr Meguru Achira, Dr Esther Bouman-Thio, Mr Akira Shishido, Ms Joyce Ford, Dr Gopi Shankar, Dr Carrie Wagner, Dr Kenneth T. Kim, Dr Hugh M. Davis and Dr Honghui Zhou

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009355162

  12. Update on biologic therapies in ankylosing spondylitis: a literature review

    International Journal of Rheumatic Diseases

    Volume 15, Issue 5, October 2012, Pages: 445–454, Leslie Goh and Ash Samanta

    Version of Record online : 8 JUL 2012, DOI: 10.1111/j.1756-185X.2012.01765.x

  13. You have free access to this content
    Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four–week efficacy and safety results of a randomized, placebo-controlled study

    Arthritis & Rheumatism

    Volume 60, Issue 4, April 2009, Pages: 976–986, Arthur Kavanaugh, Iain McInnes, Philip Mease, Gerald G. Krueger, Dafna Gladman, Juan Gomez-Reino, Kim Papp, Julie Zrubek, Surekha Mudivarthy, Michael Mack, Sudha Visvanathan and Anna Beutler

    Version of Record online : 30 MAR 2009, DOI: 10.1002/art.24403

  14. You have free access to this content
    Golimumab, a new human anti–tumor necrosis factor α antibody, administered intravenously in patients with active rheumatoid arthritis: Forty-eight–week efficacy and safety results of a phase III randomized, double-blind, placebo-controlled study

    Arthritis & Rheumatism

    Volume 62, Issue 4, April 2010, Pages: 917–928, Joel Kremer, Christopher Ritchlin, Alan Mendelsohn, Daniel Baker, Lilianne Kim, Zhenhua Xu, John Han and Peter Taylor

    Version of Record online : 28 JAN 2010, DOI: 10.1002/art.27348

  15. You have free access to this content
    Comparison of three methods for calculating the Bath Ankylosing Spondylitis Metrology Index in a randomized placebo-controlled study

    Arthritis Care & Research

    Volume 64, Issue 12, December 2012, Pages: 1919–1922, Désirée van der Heijde, Atul Deodhar, Robert D. Inman, Jürgen Braun, Ben Hsu and Michael Mack

    Version of Record online : 28 NOV 2012, DOI: 10.1002/acr.21771

  16. You have free access to this content
    Golimumab reduces sleep disturbance in patients with active ankylosing spondylitis: Results from a randomized, placebo-controlled trial

    Arthritis Care & Research

    Volume 62, Issue 9, September 2010, Pages: 1266–1271, Atul Deodhar, Jürgen Braun, Robert D. Inman, Michael Mack, Shreekant Parasuraman, Jacqueline Buchanan, Benjamin Hsu, Tim Gathany and Désirée van der Heijde

    Version of Record online : 2 SEP 2010, DOI: 10.1002/acr.20233

  17. You have full text access to this OnlineOpen article
    Patient-Reported Outcomes and the Association With Clinical Response in Patients With Active Psoriatic Arthritis Treated With Golimumab: Findings Through 2 Years of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

    Arthritis Care & Research

    Volume 65, Issue 10, October 2013, Pages: 1666–1673, Arthur Kavanaugh, Iain B. McInnes, Gerald G. Krueger, Dafna Gladman, Anna Beutler, Tim Gathany, Michael Mack, Neeta Tandon, Chenglong Han and Philip Mease

    Version of Record online : 24 SEP 2013, DOI: 10.1002/acr.22044

  18. You have free access to this content
    Significant improvement in synovitis, osteitis, and bone erosion following golimumab and methotrexate combination therapy as compared with methotrexate alone: A magnetic resonance imaging study of 318 methotrexate-naive rheumatoid arthritis patients

    Arthritis & Rheumatism

    Volume 63, Issue 12, December 2011, Pages: 3712–3722, Mikkel Østergaard, Paul Emery, Philip G. Conaghan, Roy Fleischmann, Elizabeth C. Hsia, Weichun Xu and Mahboob U. Rahman

    Version of Record online : 29 NOV 2011, DOI: 10.1002/art.30592

  19. You have free access to this content
    Golimumab Therapy of Rheumatoid Arthritis: An Overview

    Scandinavian Journal of Immunology

    Volume 72, Issue 2, August 2010, Pages: 75–85, I. Zidi, A. Bouaziz, W. Mnif, A. Bartegi, F. A. Al-Hizab and N. B. Amor

    Version of Record online : 7 JUN 2010, DOI: 10.1111/j.1365-3083.2010.02423.x

  20. You have full text access to this OnlineOpen article
    Efficacy and Safety of Subcutaneous Golimumab in Methotrexate-Naive Patients With Rheumatoid Arthritis: Five-Year Results of a Randomized Clinical Trial

    Arthritis Care & Research

    Volume 68, Issue 6, June 2016, Pages: 744–752, Paul Emery, Roy M. Fleischmann, Ingrid Strusberg, Patrick Durez, Peter Nash, Eric Jason B. Amante, Melvin Churchill, Won Park, Bernardo Pons-Estel, Chenglong Han, Timothy A. Gathany, Stephen Xu, Yiying Zhou, Jocelyn H. Leu and Elizabeth C. Hsia

    Version of Record online : 26 MAY 2016, DOI: 10.1002/acr.22759